These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 7508536)

  • 21. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.
    Radermacher J; Meiners M; Bramlage C; Kliem V; Behrend M; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
    Transpl Int; 1998; 11(1):3-10. PubMed ID: 9503547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis.
    Al-Awwa IA; Hariharan S; First MR
    Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S15-8. PubMed ID: 9631859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.
    Textor SC; Wiesner R; Wilson DJ; Porayko M; Romero JC; Burnett JC; Gores G; Hay E; Dickson ER; Krom RA
    Transplantation; 1993 Jun; 55(6):1332-9. PubMed ID: 7685934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients.
    Devlin J; Williams R; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Bismuth H; Groth C
    Transpl Int; 1994; 7 Suppl 1():S22-6. PubMed ID: 11271207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients.
    Williams AW; Morgenstern BZ; Murphy M; Milliner DS
    Pediatr Nephrol; 1994 Oct; 8(5):566-9. PubMed ID: 7819002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.
    Knight RJ; Podder H; Kerman RH; Lawless A; Katz SM; Van Buren CT; Gaber AO; Kahan BD
    Transplantation; 2010 Mar; 89(6):727-32. PubMed ID: 20195219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR; Lin CC; Lian JD
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular and tubular function following orthotopic liver transplantation in children.
    McLin VA; Girardin E; Lecoultre C; Mentha G; Belli DC
    Pediatr Transplant; 2005 Aug; 9(4):512-9. PubMed ID: 16048605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation.
    Brennan DC; Stratta RJ; Lowell JA; Miller SA; Taylor RJ
    Transplantation; 1994 Jun; 57(11):1606-11. PubMed ID: 8009595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.
    Porayko MK; Gonwa TA; Klintmalm GB; Wiesner RH
    Transplant Proc; 1995 Feb; 27(1):1114-6. PubMed ID: 7533358
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs.
    Burdmann EA; Andoh TF; Lindsley J; Russell J; Bennett WM; Porter G
    Ren Fail; 1994; 16(1):161-8. PubMed ID: 7514309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
    Herrero JI; Quiroga J; Sangro B; Girala M; Gómez-Manero N; Pardo F; Alvárez-Cienfuegos J; Prieto J
    Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO
    Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.
    Cantarovich D; Renou M; Megnigbeto A; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Karam G; Soulillou JP
    Transplantation; 2005 Jan; 79(1):72-8. PubMed ID: 15714172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.
    Pachon J; Lorber MI; Bia MJ
    Transplantation; 1989 Feb; 47(2):254-9. PubMed ID: 2645708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.